These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10378306)

  • 1. [Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1999; 45(2):158-64. PubMed ID: 10378306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urokinase as a blood and urine plasminogen activator in chronic glomerulonephritis and amyloidosis].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV; Bumblite ID
    Vestn Ross Akad Med Nauk; 1999; (2):58-61. PubMed ID: 10204025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of a protein loading test on the fibrinolytic system in patients with chronic glomerulonephritis and amyloidosis].
    Poliantseva LR; Bumblite ID; Andreenko GV; Podorol'skaia LV; Zverev KV
    Ter Arkh; 1992; 64(6):19-21. PubMed ID: 1440329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].
    Smyr KV; Shcherbak AV; Kozlovskaia LV; Sokolova IA; Bobkova IN; Podorol'skaia LV
    Ter Arkh; 2010; 82(1):47-51. PubMed ID: 20364701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activators and inhibitors of fibrinolysis in chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1996; 42(4):322-7. PubMed ID: 9254520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipiduria in the nephrotic syndrome].
    Neverov NI; Nikitina EA
    Ter Arkh; 1992; 64(6):16-8. PubMed ID: 1440328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator in nephrotic syndrome.
    Andreenko GV; Podoroldskaya LV; Polyantseva LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):351-5. PubMed ID: 2465229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [R proteins as a reflection of disorders in the cellular reception mechanisms in kidney diseases].
    Kozlovskaia LV; Zaĭtseva LI; Karryeva BCh; Kulagina NN; Artem'eva VB
    Ter Arkh; 1992; 64(4):79-81. PubMed ID: 1332207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis.
    Nielsen JD; Gram J; Holm-Nielsen A; Fabrin K; Jespersen J
    Br J Urol; 1997 Dec; 80(6):889-93. PubMed ID: 9439403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of IL-8 and defensins in pathogenesis of chronic glomerulonephritis and pyelonephritis].
    Rebenok AZh; Tikhonov II; Chizh AS
    Ter Arkh; 1999; 71(8):62-7. PubMed ID: 10515041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of nitric oxide levels in patients with chronic glomerulonephritis].
    Barbarash OL; Pavlova VIu; Chesnokova IuL; Bazdyrev ED; Malyshev IIu; Manukhina EB
    Klin Med (Mosk); 2007; 85(5):57-61. PubMed ID: 17665607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary fibrinolytic enzyme activity in systemic diseases and chronic glomerulonephritis].
    Palienko IA; Belitskaia GA
    Vrach Delo; 1988 Feb; (2):71-3. PubMed ID: 3381527
    [No Abstract]   [Full Text] [Related]  

  • 16. [A substrate inhibitor analysis of the urinary excretion of tissue and plasma kallikreins in patients with chronic glomerulonephritis].
    Platonova LV; Poliantseva LR; Filatova MP; Paskhina TS
    Urol Nefrol (Mosk); 1990; (4):38-43. PubMed ID: 2275058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of the study of hemostasis in nephrology].
    Mukhin NA; Poliantseva LR; Kozlovskaia LV; Kozlovskaia NL; Charyev BM
    Ter Arkh; 1988; 60(6):7-13. PubMed ID: 3206376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN; Kozlovskaia LV; Rameeva AS; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z
    Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN; Chebotareva NV; Kozlovskaia LV; Varshavskiĭ VA; Golitsyna EP
    Ter Arkh; 2006; 78(5):9-14. PubMed ID: 16889042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.